Sepsis outcome is determined by a balance between inflammation and immune suppression. We aimed to evaluate monocytes polarization and reprogramming during these processes.
A R T I C L E I N F O A B S T R A C T
Sepsis outcome is determined by a balance between inflammation and immune suppression. We aimed to evaluate monocytes polarization and reprogramming during these processes.
We analyzed 93 patients with procalcitonin level >0.5 ng/mL (hPCT) and suspected/confirmed sepsis, and 84 controls by analysis of CD14, CD16 and HLA-DR expression on blood monocytes using fluorescent labeled monoclonal antibodies and BD FACS CANTO II.
Complete blood cell count, procalcitonin and other biochemical markers were evaluated.
Intermediate monocytes CD14 ++ CD16 + increased in hPCT patients (including both positive and negative culture) compared to controls (13.6% ± 0.8 vs 6.2% ± 0.3, p<0.001), while classical monocytes CD14 ++ CD16 -were significantly reduced (72.5% ± 1.6 vs 82.6% ± 0.7, p<0.001). Among hPCT patients having positive microbial culture, the percentage of intermediate
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monocytes was significantly higher in septic compared with non-septic/localized-infection patients (17.4% vs 11.5%; p<0.05) whilst the percentage of classical monocytes was lower (68.0% vs 74.5%). Three-four days following the diagnosis of sepsis, HLA-DR expression on monocyte (mHLA-DR) was lower (94.3%) compared to controls (99.4%) (p<0.05). Septic patients with the worst clinical conditions showed higher incidence of secondary infections, longtime hospitalization and lower HLA-DR + monocytes compared to septic patients with better clinical outcome (88.4% vs 98.6%, p=0.05).
The dynamic nature of sepsis correlates with monocytes functional polarization and reprogramming from a pro-inflammatory CD14
++

CD16
+ phenotype in non-septic hPCT patients to a decrease of HLA-DR surface expression in hPCT patients with confirmed sepsis, making HLA-DR reduction a marker of immune-paralysis and sepsis outcome.
Analysis of monocytes plasticity opens to new mechanisms responsible for pro/anti-inflammatory responses during sepsis, and new immuno therapies.
INTRODUCTION
A major defense mechanism against infection and tissue injury is provided by the innate immune system through inflammation (1 (2) . These subsets are associated with specific functions.
Classical monocytes show antimicrobial potential, while CD16 positive monocytes are involved in antigen processing and presentation as well as trans-endothelial migration (3) . The expansion of the CD16 positive monocytes has been observed in many different types of disorders, especially infection or inflammatory conditions (4).
The host immune response during sepsis is complex and variable over time. The first phase is characterized by an overwhelming inflammation also known as the "cytokine storm", during which blood monocytes release high levels of pro-inflammatory cytokines (e.g. TNF-α and IL-1) (5). This phase is followed by a stage of immune-suppression in which patients are characterized by persistent inflammation, neutrophilia, lymphopenia and they are more susceptible to secondary infections due to a dysregulation of innate and adaptive immunity (6) . In this stage of immune-paralysis, monocytes are functionally deactivated and show decreased release of pro-inflammatory cytokines and decreased antigen presenting capacity because of low HLA-DR surface expression (7).
Human leukocyte antigen DR (HLA-DR) is a cell surface receptor involved in antigen presentation to the adaptive immune system for the purpose of stimulating T cell responses. Many clinical studies have associated the low levels of HLA-DR expression on circulating monocytes with the increased risk of adverse outcome or death of septic patients and increased susceptibility to contracting secondary/nosocomial infections (8) (9) (10) . For this reason, among all biological parameters, the evaluation of HLA-DR levels on monocytes surface represents the most studied marker to establish their anergy and the general immuno-paralysis state of patients (11) (12) (10, 11) .
In the present study, we investigated the phenotypic and functional changes in different monocyte subsets from inflammatory state to septic state by flow cytometry analysis in order to evaluate monocytes polarization and reprogramming during these processes.
MATERIALS AND METHODS
Patients
The present study has been conducted on 93 patients hospitalized in different medical and surgical wards of the Vito Fazzi Hospital of Lecce (Italy) with high procalcitonin plasmatic levels (PCT > 0.5 ng/mL) and suspected bacterial infection, based on several clinical suspicions. 84 not hospitalized healthy individuals were used as controls.
For each patient, clinical and biological variables were collected. These included demographic characteristics (age and gender), microbiological findings (infection source and the identified microorganisms) and routine markers of inflammation as PCT, C-reactive protein (CRP), complete blood cell count and biochemical markers.
Sepsis diagnosis has been established according to Society of Critical Care Medicine and the European Society of Intensive Care Medicine (13) . Written informed consent was obtained from the patients or, if not possible, from their relative as designed by ethic committee.
Hematochemical investigation
Complete blood count was performed on a Sysmex XE-2100 Automatic Hematology Analyzer (Sysmex, Kobe, Japan). Plasmatic levels of PCT were determined by Enzyme-Linked Fluorescence Assay (ELFA) with the VIDAS ® B.R.A.H.M.S. PCT™ system (Biomerieux, Marcy-l'Etoile, France), according to manufacturer recommendations and expressed in ng/mL. Serum levels of CRP were measured immuneturbidometrically on the analyzer Roche/Hitachi MODULAR P, according to manufacturer recommendations (Roche Diagnostic GmbH) and expressed in mg/L.
All others biochemicals parameters analyzed were performed on Modular Cobas ® 8000 according to manufacturer directions (Roche Diagnostic GmbH).
Microbiological cultural assay
Microbial cultures were used to determine the type of organism present in different biological specimens derived from different site (respiratory tract, urinary tract, abdomen, and others) according to clinical suspicion and test requested to the laboratory by standardized microbiological cultural assays procedures.
Blood cultures were performed in patients with clinical symptoms of bloodstream infections prior the administration of antimicrobial therapy. For each patient, two bottles sets were used for each septic episode; approximately 10 mL of blood was inoculated in the aerobic and anaerobic bottle (BACT/ALERT Culture Media, Biomerieux, Marcy-l'Etoile,France); the bottles were entered in the BACT/ALERT 3D System for the incubation and measure of the color change in response to shift in pH as a result of rising of CO 2 levels produced by microorganisms. In positive samples, bacteria and yeasts were identified on the Vitek 2 system (Biomerieux, Marcyl'Etoile, France), according to manufacturer directions.
Flow cytometrical analysis
For monocytes phenotypic analysis, 100µL of EDTA anticoagulated whole blood from patients and controls were incubated with the following combination of monoclonal antibodies: 20 μL of 
Statistical analysis
Statistical analysis was performed by MedCalc v19.9.1 statistical software. Data were presented as the mean ± SEM (Standard Error of the Mean). The Student's t-test was used for comparison between patients and controls; statistically significant differences were established by p value (< 0.05).
RESULTS
The population of 93 hospitalized patients analyzed in the present study was enrolled according to high plasmatic level of procalcitonin (PCT > 0.5 ng/ml, hPCT) while 84 not hospitalized healthy individuals were used as controls. Demographic and clinical characteristics of all individuals are shown in Table 1 .
Total white blood cells, monocytes and neutrophils counts were significantly higher in patients compared to controls (Table 1) , while lymphocytes count was significantly reduced (Table 1) . 24,7% of hPCT patients with negative cultural assay (Cult-NEG, n=23, Table 2 ) showed a condition defined "strong inflammatory state" characterized by alteration of white blood cells count (13.0 ± 1.6 x 10 9 /L, reference range 4.0-10.0 x 10 9 /L) and hematological parameters, increased C-reactive protein plasmatic levels (115.0 ± 16.5 mg/L, reference range 0.0-10.0 mg/L), as well as some liver markers (i.e. AST 54.4 ± 18.8 U/L, reference range <45 U/L; GGT 85.9 ± 26.1 U/L, reference range <45 U/L) and total bilirubin (3.0 ± 1.9 mg/ dL, reference range <1.25 mg/dL).
The remaining 75,3% of hPCT patients showed positive cultural assay demonstrating the presence of "infection" in different site as blood, respiratory tract, urinary tract, abdomen, and others (Cult-POS, n=70, Table 2 ). Among infection-positive patients, 68.6% were infected by Gram negative bacteria, 21,4% by Gram positive bacteria and 10% by Candida. In a small number of septic patients (n=23), biochemical and hematological parameters were monitored at admission (time 1), at blood culture request (time 2), after 3-4 days from diagnosis (time 3), as well as after 6-7 days from diagnosis (time 4).
The samples were retrospectively categorized into two groups characterized by better clinical outcome (group BO) or worst clinical outcome (group WO) based on time of hospitalization, recovery time from primary infection, appearance of secondary/nosocomial infections and death. Clinical characteristics of subgroups with better and worst clinical outcome are shown in Table 3 .
Blood monocyte subsets
Monocytes subsets were differentiated by flow cytometrical analysis on the basis of CD14 and CD16 surface expression.
Intermediate monocytes CD14 ++ CD16 + were significantly increased in hPCT patients compared to controls (13.6% ± 0.8 and 6.2% ± 0.3 respectively with p<0.001), while classical monocytes CD14 ++ CD16 -were significantly reduced (72.5% ± 1.6 vs 82.6% ± 0.7, p<0.001). Non-classical monocytes didn't show significant differences between patients and controls (5.5% ± 0.9 and 5.1% ± 0.3 respectively with p=0.6).
The differences between subsets of monocytes from hPCT patients with infection (Cult-POS) and with inflammatory state (Cult-NEG) were not significant: in both patient groups, intermediate monocytes remained significantly increased compared to healthy controls ( Figure 1 ) highlighting a pro-inflammatory phenotype for all hPCT patients.
Cult-POS infected patients included both septic patients (BC+) and non-septic patients (BC-)presenting infection in other body sites, excluding bloodstream infection).
Intermediate monocytes were significantly increased in BC+ compared to BC-(17.4% ± 2.1 According to the role of CD16 positive monocytes in modulating inflammatory response, a positive correlation trend between procalcitonin level and intermediate CD14 ++ CD16 + monocytes percentages was observed; on the other hand, classical monocytes showed an opposite trend of correlation with the increase of procalcitonin (Figure 2 ).
HLA-DR monocytes surface expression in septic patients
HLA-DR monocytes surface (mHLA-DR) expression was analyzed by flow cytometrical analysis (Figure 3 A, B, C) . Percentage of mHLA-DR and MFI in non-septic patients (BC-) showed no significant difference compared to controls (99.1% ± 0.3 vs 99.4% ± 0.2 respectively with p=0.3). In septic patients, HLA-DR expression on all monocytes subsets was significantly lower (BC+, 94.3% ± 2.2) compared to healthy controls (99.4% ± 0.2, with p<0.05) ( Figure 3D ). As figure; where not indicated, difference was not statistically significant).
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previously reported (11) , in septic patients mH-LA-DR was estimated 3-4 days after diagnosis of sepsis. mHLA-DR expression in BC+ patients was significantly lower than BC-patients (94.3% ± 2.2 vs 99.1% ± 0.3 with p<0.05) ( Figure 3D ). No statistical significance was observed for mHLA-DR MFI between BC+, BC-and control patients.
Among septic patients, the subgroup WO showed worst conditions, characterized by higher incidence of secondary/nosocomial infections, often polymicrobial, as well as long time hospitalization (>30 days).
We separately analyzed subgroup WO and, in agreement with the known sepsis-induced immune system alterations, we found that these patients had lower percentage of HLA-DR positive monocytes compared with better outcome patients (BO subgroup) (88.4% ± 4.5 and 98.6% ± 0.3, respectively, with p=0.05, 10% reduction, Figure 3E ) associated with lower mHLA-DR MFI (Mode 1193.6 ± 219.6 and 2819.4 ± 591.1, respectively, with p=0.022, 58% reduction) ( Figure 3F ), and also lower Median of Florescence Intensities (1623.7 ± 416.3 and 2730.8 ± 332.5, respectively, with p=0.05) or Mean of Florescence Intensities (2344.0 ± 590.2 and 3837.4 ± 398.1, respectively, with p=0.05). Similarly, significant 11% reduction of mHLA-DR percentage and 46% reduction of mHLA-DR MFI was obtained by comparing worst condition and control patients ( Figure 3E and F) .
Interestingly, the worst condition patients didn't show a tendency towards restoration of normal values of white blood cells, platelets, monocytes, neutrophils and lymphocytes counts like better outcome patients ( Figure 4 , Table 3 ) as well as BC-patients, which however showed more stable hematological parameters than BC+ (data not shown).
DISCUSSION
Impaired immune response following sepsis originates from delayed restoration of immunologic homeostasis between pro-and anti-inflammatory responses and determines higher risk for adverse outcome including secondary 
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infection and death (7). The innate immune cells (including monocytes) are involved in the initial immunologic response to critical illness with the adaptative response being more prevalent in the subacute phase of illness. In the present study, we analyzed monocytes polarization and reprogramming from inflammatory to immunosuppressive phase in critical ill patients with high procalcitonin serum levels (>0.5 ng/mL). These patients showed a significant shift to a proin- 
CD16
-monocytes subpopulation ( Figure 1C ). Intermediate monocytes mainly exert a pro-inflammatory role. CD16
+ monocytes are recognized to be involved in antigen processing and presentation as well as trans-endothelial migration (3) and to be increased during inflammation (e.g., cancer, sepsis and stroke), infections such as HIV (14) (15) (16) (17) , tuberculosis (18) and other pathogens (19, 20) . Accordingly, in our study, intermediate monocytes were significantly increased during both "strong inflammatory state" (Cult-Neg) and "infection state", identified by a positive microbiological cultural assay figure; where not indicated, difference was not statistically significant). (20) . Leukocytes trafficking occurs in presence of increased vascular permeability and endothelial activation during sepsis; these processes are controlled by molecular mediators in the context of the regulation of the pro-anti-inflammatory response (22) .
D: mHLA-DR expression in hPCT-patients; in septic patients (BC+), HLA-DR expression is significantly lower compared to non-septic patients (BC-) and healthy controls (Ctrl).
E and F: subgroup of septic patients presenting worst outcome (BC+, group WO) shows a significant reduction of mHLA-DR percentage and relative MFI compared to patients with better clinical outcome (group BO) and healthy controls (Ctrl). (P values indicated in
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Figure 4 Evaluation of hemato-chemical markers during hospitalization time
When severe and persistent compensatory antiinflammatory response follows critical illness, patient is exposed to high risk for adverse outcome. As known, monocytes normally recognize and process the pathogen and present the antigens on their cell surface via human leukocytes antigen HLA-DR molecules; when activated, monocytes secrete proinflammatory cytokines, such as TNF-α, which amplify the immune response. As critical condition progresses, lower mHLA-DR expression determines a reduced monocytes antigen presenting capacity and releasing of pro-inflammatory cytokines in response to bacterial compounds and immunesuppressed state (9, 23, 24) . In this setting, we examined mHLA-DR expression in hPCT-patients population of the present study, and we found a significant percentage reduction in septic patients compared to controls and to BC-patients ( Figure 3D) . Notably, subgroup of septic patients presenting worst outcome (BC+, group WO) showed a significant reduction of mHLA-DR percentage ( Figure 3E ) and of mHLA-DR quantification as MFI (mode of florescence intensity) which is an indicator of a reduced number of HLA-DR molecule per monocytes ( Figure 3F ). Time course evaluation of hemato-chemical markers showed worsening of the clinical conditions of WO-patients compared to restoration of same parameters in BO-patients (Figure 4, Table3) . Recently, four phenotypes of sepsis have been derived from clustering analysis of multiple data set (25, 26) , and currently not included in consensus definition of sepsis (13) , which are potentially related to biomarker variation and clinical outcome of patients. Difference between the 4 phenotypes derives from different pattern of organ dysfunction, demographic data and laboratory values: broad differences were observed in the distribution of the host immune response biomarkers across phenotypes; in general there was an increase in the markers of inflammation and of endothelial dysfunction in γ and/or δ high-mortality phenotypes compared with the α or β phenotypes with better clinical outcome (25, 26 causes lymphopenia during sepsis and has been associated with mortality and secondary infection risk (27) (28) (29) . We found that lymphocytes absolute count showed a substantial drop in WOpatients (Figure 4 ), while both BO-patients (BC+) and BC-patients showed a more stable trend.
Further studies are in progress to evaluate degree of T cell dysfunction (i.e. activation in presence of bacterial lysate) and regulatory T cell (i.e. immune-suppressive subset of T cells) in the perspective of better understanding of mechanisms responsible for pro/anti-inflammatory responses during sepsis, and develop new approaches of immuno-monitoring strategies and immunotherapies.
